1. Home
  2. ENOV

ENOV

Enovis Corporation

Logo Enovis Corporation

Industrials

Fluid Controls

Nasdaq

as 04-19-2024 11:56am EST

$
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Enovis Corp is a medical technology company focused on developing clinically differentiated solutions that generate measurable patient outcomes and transform workflows by manufacturing and distributing high-quality medical devices with a broad use for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company conducts its operations through two operating segments: Prevention & Recovery (P&R) and Reconstructive (Recon). It generates the majority of revenue from the Prevention & Recovery segment.

Founded: 1995 Country:
United States
United States
Employees: 6550 City: WILMINGTON
Market Cap: 3.1B IPO Year: 2008
Target Price: $74.88 AVG Volume (30 days): 425.2K
Analyst Decision: Strong Buy Number of Analysts: 9
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.61 EPS Growth: N/A
52 Week Low/High: $43.04 - $66.14 Next Earning Date: 05-02-2024
Revenue: $1,707,197,000 Revenue Growth: 9.22%
Revenue Growth (this year): 26.41% Revenue Growth (next year): 7.46%

Share on Social Networks: